GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jenburkt Pharmaceuticals Ltd (BOM:524731) » Definitions » E10

Jenburkt Pharmaceuticals (BOM:524731) E10 : ₹50.97 (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jenburkt Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jenburkt Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was ₹21.750. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹50.97 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Jenburkt Pharmaceuticals's average E10 Growth Rate was 12.40% per year. During the past 3 years, the average E10 Growth Rate was 9.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jenburkt Pharmaceuticals was 9.90% per year. The lowest was 9.90% per year. And the median was 9.90% per year.

As of today (2024-12-15), Jenburkt Pharmaceuticals's current stock price is ₹1312.30. Jenburkt Pharmaceuticals's E10 for the quarter that ended in Sep. 2024 was ₹50.97. Jenburkt Pharmaceuticals's Shiller PE Ratio of today is 25.75.

During the past 13 years, the highest Shiller PE Ratio of Jenburkt Pharmaceuticals was 24.79. The lowest was 10.59. And the median was 15.23.


Jenburkt Pharmaceuticals E10 Historical Data

The historical data trend for Jenburkt Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenburkt Pharmaceuticals E10 Chart

Jenburkt Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 35.57 37.04 42.29 47.27

Jenburkt Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.33 46.28 47.27 49.27 50.97

Competitive Comparison of Jenburkt Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Jenburkt Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jenburkt Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jenburkt Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jenburkt Pharmaceuticals's Shiller PE Ratio falls into.



Jenburkt Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jenburkt Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=21.75/157.8822*157.8822
=21.750

Current CPI (Sep. 2024) = 157.8822.

Jenburkt Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201412 6.490 96.780 10.587
201503 4.810 97.163 7.816
201506 5.490 99.841 8.682
201509 7.380 101.753 11.451
201512 7.530 102.901 11.553
201603 2.780 102.518 4.281
201606 4.190 105.961 6.243
201609 10.884 105.961 16.217
201612 6.350 105.196 9.530
201703 7.600 105.196 11.406
201706 -6.190 107.109 -9.124
201709 21.450 109.021 31.063
201712 9.890 109.404 14.272
201803 12.150 109.786 17.473
201806 5.880 111.317 8.340
201809 12.520 115.142 17.167
201812 9.720 115.142 13.328
201903 15.020 118.202 20.062
201906 0.130 120.880 0.170
201909 12.100 123.175 15.509
201912 10.110 126.235 12.645
202003 10.060 124.705 12.736
202006 2.200 127.000 2.735
202009 12.360 130.118 14.997
202012 12.960 130.889 15.633
202103 8.450 131.771 10.124
202106 10.130 134.084 11.928
202109 17.370 135.847 20.188
202112 13.570 138.161 15.507
202203 7.510 138.822 8.541
202206 12.970 142.347 14.385
202209 14.960 144.661 16.327
202212 11.840 145.763 12.824
202303 14.130 146.865 15.190
202306 12.170 150.280 12.786
202309 16.590 151.492 17.290
202312 12.250 152.924 12.647
202403 17.860 153.035 18.426
202406 16.800 155.789 17.026
202409 21.750 157.882 21.750

Add all the adjusted EPS together and divide 10 will get our e10.


Jenburkt Pharmaceuticals  (BOM:524731) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jenburkt Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1312.30/50.97
=25.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jenburkt Pharmaceuticals was 24.79. The lowest was 10.59. And the median was 15.23.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jenburkt Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Jenburkt Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Jenburkt Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
93, Jayprakash Road, Nirmala Apartments, Andheri (West), Mumbai, MH, IND, 400058
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.

Jenburkt Pharmaceuticals Headlines

No Headlines